Q62245
Gene name |
Sos1 |
Protein name |
Son of sevenless homolog 1 |
Names |
SOS-1 , mSOS-1 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:20662 |
EC number |
|
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
776-1020 (Ras guanine-nucleotide exchange factors catalytic domain) |
Relief mechanism |
Partner binding |
Assay |
|
Target domain |
776-1020 (Ras guanine-nucleotide exchange factors catalytic domain) |
Relief mechanism |
Ligand binding |
Assay |
|
Accessory elements
No accessory elements
References
- Tartaglia M et al. (2010) "Noonan syndrome: clinical aspects and molecular pathogenesis", Molecular syndromology, 1, 2-26
- Sondermann H et al. (2004) "Structural analysis of autoinhibition in the Ras activator Son of sevenless", Cell, 119, 393-405
- Gureasko J et al. (2010) "Role of the histone domain in the autoinhibition and activation of the Ras activator Son of Sevenless", Proceedings of the National Academy of Sciences of the United States of America, 107, 3430-5
Autoinhibited structure

Activated structure

68 variants for Q62245
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs3389489700 | 59 | L>Q | No | EVA | |
rs3389429981 | 94 | I>F | No | EVA | |
rs3389477284 | 101 | N>K | No | EVA | |
rs3389489745 | 138 | S>C | No | EVA | |
rs3389480800 | 160 | Q>P | No | EVA | |
rs3389482935 | 180 | V>E | No | EVA | |
rs3408084830 | 213 | R>L | No | EVA | |
rs3389477257 | 265 | D>V | No | EVA | |
rs3389477306 | 320 | A>V | No | EVA | |
rs3389477285 | 322 | L>F | No | EVA | |
rs3389473738 | 334 | A>T | No | EVA | |
rs3389483009 | 347 | V>M | No | EVA | |
rs864299442 | 352 | H>Q | No | EVA | |
rs3389440036 | 352 | H>Y | No | EVA | |
rs3389477288 | 354 | F>L | No | EVA | |
rs1134521164 | 370 | K>* | No | EVA | |
rs1133394635 | 377 | I>V | No | EVA | |
rs1134692085 | 382 | N>I | No | EVA | |
rs3389494776 | 420 | K>N | No | EVA | |
rs3389440100 | 426 | Q>* | No | EVA | |
rs3389482987 | 433 | E>D | No | EVA | |
rs3389480757 | 434 | G>E | No | EVA | |
rs221516702 | 485 | S>T | No | EVA | |
rs3389440072 | 540 | A>V | No | EVA | |
rs3389483168 | 541 | L>V | No | EVA | |
rs3408199792 | 549 | T>I | No | EVA | |
rs3407404440 | 553 | M>V | No | EVA | |
rs260206898 | 566 | Q>H | No | EVA | |
rs3389473766 | 566 | Q>L | No | EVA | |
rs3389392422 | 637 | P>L | No | EVA | |
rs3389485279 | 639 | E>D | No | EVA | |
rs3389477280 | 639 | E>G | No | EVA | |
rs3389440107 | 717 | F>S | No | EVA | |
rs3389440032 | 733 | I>T | No | EVA | |
rs3408042947 | 753 | T>A | No | EVA | |
rs3406196557 | 754 | F>C | No | EVA | |
rs3408042999 | 758 | P>T | No | EVA | |
rs3389462147 | 760 | T>I | No | EVA | |
rs3389483147 | 762 | E>K | No | EVA | |
rs3406196617 | 763 | W>* | No | EVA | |
rs3406196587 | 764 | H>Q | No | EVA | |
rs3389482934 | 772 | E>D | No | EVA | |
rs3389475491 | 798 | A>G | No | EVA | |
rs3389462088 | 816 | I>N | No | EVA | |
rs3389448521 | 851 | V>L | No | EVA | |
rs3389430002 | 864 | E>* | No | EVA | |
rs3408084869 | 869 | N>H | No | EVA | |
rs3408084831 | 871 | V>L | No | EVA | |
rs3389429979 | 875 | V>L | No | EVA | |
rs3389429961 | 877 | A>D | No | EVA | |
rs3389498944 | 887 | D>Y | No | EVA | |
rs3389462081 | 950 | R>G | No | EVA | |
rs3389429990 | 960 | K>N | No | EVA | |
rs3389477311 | 976 | N>K | No | EVA | |
rs3389392436 | 1000 | S>C | No | EVA | |
rs249950894 | 1020 | H>P | No | EVA | |
rs3389462110 | 1036 | K>N | No | EVA | |
rs3389477348 | 1038 | P>R | No | EVA | |
rs3389440065 | 1052 | H>Y | No | EVA | |
rs3389485269 | 1068 | I>T | No | EVA | |
rs3389482969 | 1128 | K>E | No | EVA | |
rs864269837 | 1136 | P>A | No | EVA | |
rs3389392404 | 1185 | S>P | No | EVA | |
rs3389392368 | 1195 | E>D | No | EVA | |
rs3413061824 | 1221 | P>S | No | EVA | |
rs3389477312 | 1237 | N>K | No | EVA | |
rs3407686333 | 1261 | S>* | No | EVA | |
rs3389429980 | 1277 | P>R | No | EVA |
No associated diseases with Q62245
5 regional properties for Q62245
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Dbl homology (DH) domain | 200 - 390 | IPR000219 |
domain | Ras-like guanine nucleotide exchange factor, N-terminal | 596 - 741 | IPR000651 |
domain | Pleckstrin homology domain | 443 - 548 | IPR001849 |
domain | Ras guanine-nucleotide exchange factors catalytic domain | 776 - 1020 | IPR001895 |
conserved_site | Ras guanine-nucleotide exchange factor, conserved site | 927 - 960 | IPR019804 |
4 GO annotations of cellular component
Name | Definition |
---|---|
cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
GTPase complex | A protein complex which is capable of GTPase activity. |
neuronal cell body | The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
5 GO annotations of molecular function
Name | Definition |
---|---|
epidermal growth factor receptor binding | Binding to an epidermal growth factor receptor. |
guanyl-nucleotide exchange factor activity | Stimulates the exchange of GDP to GTP on a signaling GTPase, changing its conformation to its active form. Guanine nucleotide exchange factors (GEFs) act by stimulating the release of guanosine diphosphate (GDP) to allow binding of guanosine triphosphate (GTP), which is more abundant in the cell under normal cellular physiological conditions. |
molecular condensate scaffold activity | Binding and bringing together two or more macromolecules in contact, permitting those molecules to organize as a molecular condensate. |
protein heterodimerization activity | Binding to a nonidentical protein to form a heterodimer. |
SH3 domain binding | Binding to a SH3 domain (Src homology 3) of a protein, small protein modules containing approximately 50 amino acid residues found in a great variety of intracellular or membrane-associated proteins. |
33 GO annotations of biological process
Name | Definition |
---|---|
B cell homeostasis | The process of regulating the proliferation and elimination of B cells such that the total number of B cells within a whole or part of an organism is stable over time in the absence of an outside stimulus. |
B cell receptor signaling pathway | The series of molecular signals initiated by the cross-linking of an antigen receptor on a B cell. |
blood vessel morphogenesis | The process in which the anatomical structures of blood vessels are generated and organized. The blood vessel is the vasculature carrying blood. |
cardiac atrium morphogenesis | The process in which the cardiac atrium is generated and organized. A cardiac atrium receives blood from a vein and pumps it to a cardiac ventricle. |
epidermal growth factor receptor signaling pathway | The series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription. |
ERBB2-ERBB3 signaling pathway | The series of molecular signals initiated by binding of a ligand to a ERBB3 receptor on the surface of a cell, followed by transmission of the signal by a heterodimeric complex of ERBB2 and ERBB3. ERBB2, which does not bind any known ligand, is activated through formation of a heterodimer with another ligand-activated ERBB family member such as ERBB3. ERBB3 also has impaired kinase activity and relies on ERBB2 for activation and signal transmission. |
eyelid development in camera-type eye | The progression of the eyelid in a camera-type eye from its formation to the mature state. The eyelid is a membranous cover that helps protect and lubricate the eye. |
fibroblast growth factor receptor signaling pathway | The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands. |
hair follicle development | The process whose specific outcome is the progression of the hair follicle over time, from its formation to the mature structure. A hair follicle is a tube-like opening in the epidermis where the hair shaft develops and into which the sebaceous glands open. |
heart morphogenesis | The developmental process in which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood. |
heart trabecula morphogenesis | The process of shaping a trabecula in the heart. A trabecula is a small, often microscopic, tissue element in the form of a small beam, strut or rod, which generally has a mechanical function. Trabecula are usually but not necessarily, composed of dense collagenous tissue. |
insulin receptor signaling pathway | The series of molecular signals generated as a consequence of the insulin receptor binding to insulin. |
insulin-like growth factor receptor signaling pathway | The series of molecular signals initiated by a ligand binding to an insulin-like growth factor receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
lymphocyte homeostasis | The process of regulating the proliferation and elimination of lymphocytes such that the total number of lymphocytes within a whole or part of an organism is stable over time in the absence of an outside stimulus. |
midbrain morphogenesis | The developmental process by which a midbrain is generated and organized. |
multicellular organism growth | The increase in size or mass of an entire multicellular organism, as opposed to cell growth. |
myelination | The process in which myelin sheaths are formed and maintained around neurons. Oligodendrocytes in the brain and spinal cord and Schwann cells in the peripheral nervous system wrap axons with compact layers of their plasma membrane. Adjacent myelin segments are separated by a non-myelinated stretch of axon called a node of Ranvier. |
neurotrophin TRK receptor signaling pathway | The series of molecular signals initiated by neurotrophin binding to its receptor on the surface of a target cell where the receptor possesses tyrosine kinase activity, and ending with the regulation of a downstream cellular process, e.g. transcription. |
pericardium morphogenesis | The process in which the anatomical structure of the pericardium is generated and organized. |
positive regulation of epidermal growth factor receptor signaling pathway | Any process that activates or increases the frequency, rate or extent of epidermal growth factor receptor signaling pathway activity. |
positive regulation of Ras protein signal transduction | Any process that activates or increases the frequency, rate or extent of Ras protein signal transduction. |
positive regulation of small GTPase mediated signal transduction | Any process that activates or increases the frequency, rate or extent of small GTPase mediated signal transduction. |
Ras protein signal transduction | The series of molecular signals within the cell that are mediated by a member of the Ras superfamily of proteins switching to a GTP-bound active state. |
regulation of cell population proliferation | Any process that modulates the frequency, rate or extent of cell proliferation. |
regulation of pro-B cell differentiation | Any process that modulates the frequency, rate or extent of pro-B cell differentiation. |
regulation of T cell differentiation in thymus | Any process that modulates the frequency, rate or extent of T cell differentiation in the thymus. |
regulation of T cell proliferation | Any process that modulates the frequency, rate or extent of T cell proliferation. |
regulation of transcription by RNA polymerase II | Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II. |
response to ischemia | Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a inadequate blood supply. |
roof of mouth development | The biological process whose specific outcome is the progression of the roof of the mouth from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The roof of the mouth is the partition that separates the nasal and oral cavities. |
Schwann cell development | The process aimed at the progression of a Schwann cell over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. Schwann cells are found in the peripheral nervous system, where they insulate neurons and axons, and regulate the environment in which neurons function. |
small GTPase-mediated signal transduction | The series of molecular signals in which a small monomeric GTPase relays a signal. |
vitellogenesis | The production of yolk. Yolk is a mixture of materials used for embryonic nutrition. |
28 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
A6N9I4 | RASGRP2 | RAS guanyl-releasing protein 2 | Bos taurus (Bovine) | SS |
Q1LZ97 | RASGRP4 | RAS guanyl-releasing protein 4 | Bos taurus (Bovine) | SS |
A0A3S5ZPR1 | RASGRP3 | RAS guanyl releasing protein 3 | Gallus gallus (Chicken) | SS |
P26675 | Sos | Protein son of sevenless | Drosophila melanogaster (Fruit fly) | SS |
Q5JS13 | RALGPS1 | Ras-specific guanine nucleotide-releasing factor RalGPS1 | Homo sapiens (Human) | PR |
O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | Homo sapiens (Human) | EV |
Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | Homo sapiens (Human) | EV SS |
Q86X27 | RALGPS2 | Ras-specific guanine nucleotide-releasing factor RalGPS2 | Homo sapiens (Human) | PR |
Q8IV61 | RASGRP3 | Ras guanyl-releasing protein 3 | Homo sapiens (Human) | SS |
Q8TDF6 | RASGRP4 | RAS guanyl-releasing protein 4 | Homo sapiens (Human) | SS |
Q07890 | SOS2 | Son of sevenless homolog 2 | Homo sapiens (Human) | SS |
Q13905 | RAPGEF1 | Rap guanine nucleotide exchange factor 1 | Homo sapiens (Human) | PR |
Q07889 | SOS1 | Son of sevenless homolog 1 | Homo sapiens (Human) | EV |
Q02384 | Sos2 | Son of sevenless homolog 2 | Mus musculus (Mouse) | SS |
Q9Z1S3 | Rasgrp1 | RAS guanyl-releasing protein 1 | Mus musculus (Mouse) | SS |
Q8VCC8 | Rapgef3 | Rap guanine nucleotide exchange factor 3 | Mus musculus (Mouse) | SS |
Q9EQZ6 | Rapgef4 | Rap guanine nucleotide exchange factor 4 | Mus musculus (Mouse) | EV |
Q9D300 | Rasgef1c | Ras-GEF domain-containing family member 1C | Mus musculus (Mouse) | PR |
Q03385 | Ralgds | Ral guanine nucleotide dissociation stimulator | Mus musculus (Mouse) | PR |
Q8BTM9 | Rasgrp4 | RAS guanyl-releasing protein 4 | Mus musculus (Mouse) | SS |
Q9QUG9 | Rasgrp2 | RAS guanyl-releasing protein 2 | Mus musculus (Mouse) | SS |
Q9ERD6 | Ralgps2 | Ras-specific guanine nucleotide-releasing factor RalGPS2 | Mus musculus (Mouse) | PR |
A2AR50 | Ralgps1 | Ras-specific guanine nucleotide-releasing factor RalGPS1 | Mus musculus (Mouse) | PR |
Q9R1K8 | Rasgrp1 | RAS guanyl-releasing protein 1 | Rattus norvegicus (Rat) | SS |
P0C643 | Rasgrp2 | RAS guanyl-releasing protein 2 | Rattus norvegicus (Rat) | SS |
Q8R5I4 | Rasgrp4 | RAS guanyl-releasing protein 4 | Rattus norvegicus (Rat) | SS |
Q9N5D3 | sos-1 | Son of sevenless homolog | Caenorhabditis elegans | EV |
A4IJ06 | rasgrp1 | RAS guanyl-releasing protein 1 | Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MQAQQLPYEF | FSEENAPKWR | GLLVPALKKV | QGQVHPTLES | NDDALQYVEE | LILQLLNMLC |
70 | 80 | 90 | 100 | 110 | 120 |
QAQPRSASDV | EERVQKSFPH | PIDKWAIADA | QSAIEKRKRR | NPLSLPAERI | HHLLREVLGY |
130 | 140 | 150 | 160 | 170 | 180 |
KIDHQVSVYI | VAVLEYISAD | ILKLVGNYVR | NIRHYEITKQ | DIKVAMCADK | VLMDMFHQDV |
190 | 200 | 210 | 220 | 230 | 240 |
EDINILSLTD | EEPSTSGEQT | YYDLVKAFMA | EIRQYIRELN | LIIKVFREPF | VSNSKLFSSN |
250 | 260 | 270 | 280 | 290 | 300 |
DVENIFSRIV | DIHELSVKLL | GHIEDTVEMT | DEGSPHPLVG | SCFEDLAEEL | AFDPYESYAR |
310 | 320 | 330 | 340 | 350 | 360 |
DILRPGFHGH | FLSQLSKPGA | ALYLQSIGEG | FKEAVQYVLP | RLLLAPVYHC | LHYFELLKQL |
370 | 380 | 390 | 400 | 410 | 420 |
EEKSEDQEDK | ECMKQAITAL | LNVQSGMEKI | CSKSLAKRRL | SESACRFYSQ | QMKGKQLAIK |
430 | 440 | 450 | 460 | 470 | 480 |
KMNEIQKNID | GWEGKDIGQC | CNEFIMEGTL | TRVGAKHERH | IFLFDGLMIC | CKSNHGQPRL |
490 | 500 | 510 | 520 | 530 | 540 |
PGASSAEYRL | KEKFFMRKVQ | INDKDDTSEY | KHAFEIILKD | GNSVIFSAKS | AEEKNNWMAA |
550 | 560 | 570 | 580 | 590 | 600 |
LISLQYRSTL | ERMLDVTVLQ | EEKEEQMRLP | SAEVYRFAEP | DSEENILFEE | NVQPKAGIPI |
610 | 620 | 630 | 640 | 650 | 660 |
IKAGTVLKLI | ERLTYHMYAD | PNFVRTFLTT | YRSFCRPQEL | LSLLIERFEI | PEPEPTEADR |
670 | 680 | 690 | 700 | 710 | 720 |
IAIENGDQPL | SAELKRFRKE | YIQPVQLRVL | NVCRHWVEHH | FYDFERDADL | LQRMEEFIGT |
730 | 740 | 750 | 760 | 770 | 780 |
VRGKAMKKWV | ESITKIIQRK | KIARDNGPGH | NITFQSSPPT | VEWHISRPGH | IETFDLLTLH |
790 | 800 | 810 | 820 | 830 | 840 |
PIEIARQLTL | LESDLYRAVQ | PSELVGSVWT | KEDKEINSPN | LLKMIRHTTN | LTLWFEKCIV |
850 | 860 | 870 | 880 | 890 | 900 |
ETENLEERVA | VVSRIIEILQ | VFQELNNFNG | VLEVVSAMNS | SPVYRLDHTF | EQIPSRQKKI |
910 | 920 | 930 | 940 | 950 | 960 |
LEEAHELSED | HYKKYLAKLR | SINPPCVPFF | GIYLTNILKT | EEGNPEVLRR | HGKELINFSK |
970 | 980 | 990 | 1000 | 1010 | 1020 |
RRRVAEITGE | IQQYQNQPYC | LRVEPDIKRF | FENLNPMGNS | MEKEFTDYLF | NKSLEIEPRH |
1030 | 1040 | 1050 | 1060 | 1070 | 1080 |
PKPLPRFPKK | YSYPLKSPGV | RPSNPRPGTM | RHPTPLQQEP | RKISYSRIPE | SETESTASAP |
1090 | 1100 | 1110 | 1120 | 1130 | 1140 |
NSPRTPLTPP | PASGTSSNTD | VCSVFDSDHS | ASPFHSRSAS | VSSISLSKGT | DEVPVPPPVP |
1150 | 1160 | 1170 | 1180 | 1190 | 1200 |
PRRRPESAPA | ESSPSKIMSK | HLDSPPAIPP | RQPTSKAYSP | RYSISDRTSI | SDPPESPPLL |
1210 | 1220 | 1230 | 1240 | 1250 | 1260 |
PPREPVRTPD | VFSSSPLHLQ | PPPLGKKSDH | GNAFFPNSPS | PFTPPPPQTP | SPHGTRRHLP |
1270 | 1280 | 1290 | 1300 | 1310 | |
SPPLTQEMDL | HSIAGPPVPP | RQSTSQLIPK | LPPKTYKREH | THPSMHRDGP | PLLENAHSS |